| Literature DB >> 8305834 |
D Kirsten1, U Rieger, K H Schröder, A Böhle, H Magnussen.
Abstract
Immunotherapy using bacille Calmette-Guérin (BCG) has gained increasing acceptance in the management of superficial bladder cancer. Systemic reactions after intravesical instillation of BCG are rare. However, when the therapy is complicated, the lung often becomes involved. Since the pathogenesis of lung infiltrates after immunotherapy is unknown, we report on a patient who developed a lung infiltrate after receiving BCG immunotherapy for bladder cancer. The infectious etiology was established by culture confirmation of a BCG strain in the bronchoalveolar lavage fluid.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8305834 DOI： 10.1007/BF00190319
Source DB: PubMed Journal: Clin Investig ISSN： 0941-0198